Development of engineered hematopoietic growth factors for multilineage expansion and maturation of CD34+ progenitors.

被引：0
|
作者：
Kahn, LE [1 ]
Staten, NR [1 ]
Wood, DC [1 ]
Favara, JP [1 ]
Pegg, LE [1 ]
Thomas, JW [1 ]
Burnette, BL [1 ]
Huynh, MS [1 ]
Baum, CM [1 ]
McKearn, JP [1 ]
Giri, GD [1 ]
机构：
[1] GD SEARLE & CO,SEARLE DISCOVERY RES,ST LOUIS,MO 63198
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 258
页数：1
相关论文
共 50 条
  • [21] EVIDENCE FOR AN HIV-1 MEDIATED SUPPRESSION OF INVITRO GROWTH OF ENRICHED (CD34+) HEMATOPOIETIC PROGENITORS
    ZAULI, G
    RE, MC
    FURLINI, G
    GIOVANNINI, M
    LAPLACA, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (12): : 1251 - 1253
  • [22] Ex-vivo expansion and maturation of CD34-positive hematopoietic progenitors optimization of culture conditions
    Mellado-Damas, N
    Rodríguez, JM
    Carmona, M
    González, J
    Prieto, J
    LEUKEMIA RESEARCH, 1999, 23 (11) : 1035 - 1040
  • [23] Microencapsulated feeder cells as a source of soluble factors for expansion of CD34+ hematopoietic stem cells
    Fujimoto, Nanae
    Fujita, Satoshi
    Tsuji, Takashi
    Toguchida, Junya
    Ida, Kenji
    Suginami, Hiroshi
    Iwata, Hiroo
    BIOMATERIALS, 2007, 28 (32) : 4795 - 4805
  • [24] HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors
    Zauli, G
    Capitani, S
    PATHOBIOLOGY, 1996, 64 (01) : 53 - 58
  • [25] More about multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors -: Response
    Bonig, Halvard
    Wundes, Annette
    Papayannopoulou, Thalia
    BLOOD, 2008, 112 (01) : 209 - 210
  • [26] Highly purified CD34+ cells from typical, but not variant microgranular APL, generate PML-RAR alpha negative hematopoietic progenitors.
    CarloStella, C
    LoCoco, F
    Garau, D
    Regazzi, E
    Frassoni, F
    Dotti, G
    Diverio, D
    Rizzoli, V
    BLOOD, 1995, 86 (10) : 1300 - 1300
  • [27] Bcl-2, P-glycoprotein (PgP) and Fas expression in normal CD34+ progenitors.
    Maurillo, L
    Del Poeta, G
    Venditti, A
    Epiceno, AM
    Aronica, G
    Buccisano, F
    Tamburini, A
    Bruno, A
    Caravita, T
    Battaglia, A
    Del Moro, B
    Suppo, G
    Rizzuti, V
    Amadori, S
    BLOOD, 1998, 92 (10) : 288B - 288B
  • [28] Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients
    Diez, Begona
    Genovese, Pietro
    Roman-Rodriguez, Francisco J.
    Alvarez, Lara
    Schiroli, Giulia
    Ugalde, Laura
    Rodriguez-Perales, Sandra
    Sevilla, Julian
    Diaz de Heredia, Cristina
    Holmes, Michael C.
    Lombardo, Angelo
    Naldini, Luigi
    Antonio Bueren, Juan
    Rio, Paula
    EMBO MOLECULAR MEDICINE, 2017, 9 (11) : 1574 - 1588
  • [29] Expansion of primitive megakaryocyte progenitors from CD34+ bone marrow cells.
    Garetto, L
    Severino, A
    Sanavio, F
    Danè, A
    Gammaitoni, L
    Aglietta, M
    Piacibello, W
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 769 - 769
  • [30] Systematic investigation of oxygen and growth factors in clinically valid ex vivo expansion of cord blood CD34+ hematopoietic progenitor cells
    Tursky, Melinda L.
    Collier, Fiona M.
    Ward, Alister C.
    Kirkland, Mark A.
    CYTOTHERAPY, 2012, 14 (06) : 679 - 685
12345